HLA Typing for Transplant Market worth $968 million by 2025

1
Request Sample
2
HLA Typing Transplant Market worth 8.2 billion
by 2027
MARKET OPPORTUNITY OVER NEXT 5 YEARS
TWO OF THE KEY DRIVERS OF THE MARKET WILL BE
KEY MARKET PLAYERS
CAGR of 7.0
2020 2025

• Thermo Fisher Scientific, Inc. (US)
• QIAGEN N.V. (Netherlands)
• Illumina (US)

CAGR

• HLA Typing for Transplant Market worth 968
  million by 2025

North America dominates the HLA Typing Transplant
market
Market Segmentation by Equipment category

• Based on the product, the reagents consumables
  segment held the largest share of the market
• Based on technology, the molecular assays segment
  is expected to witness the highest growth during
  the forecast period.

The demand for transplant diagnostic products for
HLA typing is expected to grow mainly due to
factors such as technological advancements, the
growing number of diagnostic centers hospitals,
increased applications in patient profiling, and
rising public-private investments to support
product development.

3
HLA Typing for Transplant Market worth 968
million by 2025
The report "HLA Typing for Transplant Market by
Technology (PCR (SSO, SSP, Real Time), Sequencing
(NGS, Sanger)), Product (Instrument, Reagent,
Software), Application (Chimerism, Antibody
Screening), End User (Hospital, Diagnolab,
Academia) - Global Forecast to 2025", is expected
to reach USD 968 million by 2025 from USD 656
million in 2019, at a CAGR of 6.7 The demand for
transplant diagnostic products for HLA typing is
expected to grow mainly due to factors such as
technological advancements, the growing number of
diagnostic centers hospitals, increased
applications in patient profiling, and rising
public-private investments to support product
development. These factors have prompted market
players to improve and strengthen their current
manufacturing and distribution capabilitiesespeci
ally in emerging markets, which are expected to
witness the highest growth. Browse 141 market
data Tables and 36 Figures spread through 193
Pages and in-depth TOC on "HLA Typing for
Transplant Market by Technology (PCR (SSO, SSP,
Real Time), Sequencing (NGS, Sanger)), Product
(Instrument, Reagent, Software), Application
(Chimerism, Antibody Screening), End User
(Hospital, Diagnolab, Academia) - Global Forecast
to 2025"View detailed Table of Content
here - https//www.marketsandmarkets.com/Market-Re
ports/transplant-diagnostics-market-96374742.html
4
HLA Typing for Transplant Market worth 968
million by 2025
Based on the product, the reagents consumables
segment held the largest share of the market in
2019. Based on the product, the HLA typing for
the transplants market is segmented into reagents
consumables, instruments, and software
services. The reagents consumables segment held
the largest share of the global HLA typing for
the transplants market in 2019. Factors such as
the increasing patient emphasis on effective and
early patient profiling during organ
transplantation and the growing adoption of
transplant diagnostic techniques (includes HLA
typing) in related research studies are driving
the growth of this segment. Based on
technology, the molecular assays segment is
expected to witness the highest growth during the
forecast period. Based on technology, the HLA
typing for the transplants market is segmented
into molecular assay and non-molecular assay
technology. The molecular assay technology
segment is expected to register the highest CAGR
during the forecast period. Factors such as its
varied applications in patient profiling, rising
public-private investments to support product
development, and increasing clinical evidence of
its efficacy are driving the growth of this
segment.
5
HLA Typing for Transplant Market worth 968
million by 2025
Based on the application, the diagnostic
application segment accounted for the largest
share of this market in 2019. Based on the
application, the HLA typing for the transplants
market is categorized into diagnostic and
research applications. Diagnostic applications
accounted for the largest share of the HLA typing
for the transplants market in 2019. Increasing
adoption of molecular assay procedures for
pathogen detection histocompatibility testing,
and the rising incidence of chronic diseases, and
supportive government regulations to increase
organ donations across major healthcare markets
are the key factors supporting the growth of this
application segment North America accounted for
the largest share of the HLA typing for
transplants market in 2019 North America
accounted for the largest share of the HLA typing
for the transplants market in 2019, followed by
Europe. This can primarily be attributed to the
continuous commercialization of innovative
transplant diagnostic products (includes HLA
typing) coupled with ongoing advancements in the
field of genomics and proteomics, recent
discovery genetic biomarkers their clinical
role in immunoassay testing, and the increasing
prevalence of chronic and communicable diseases.
6
HLA Typing for Transplant Market worth 968
million by 2025
Some of the prominent players in the HLA typing
for the transplants market are Thermo Fisher
Scientific, Inc. (US), QIAGEN N.V. (Netherlands),
Illumina (US), CareDx, Inc. (US), and Immucor,
Inc. (US). Others are Bio-Rad Laboratories, Inc.
(US), F. Hoffman-La Roche Ltd. (Switzerland),
Hologic, Inc. (US), Luminex (US), Biofortuna
(UK), Takara Bio (Japan), Omixon (Hungary),
Becton, Dickinson and Company (US), Fujirebio,
Inc. (Japan), and TBG Diagnostics Ltd.
(Australia) Dont miss out on business
opportunities in HLA Typing for Transplant
Market. Speak to our analyst and gain crucial
industry insights that will help your business
grow.
7
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 7500 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
8
Contact
Mr. Aashish Mehra MarketsandMarkets INC. 630
Dundee Road Suite 430 Northbrook, IL 60062 USA
1-888-600-6441 sales_at_marketsandmarkets.com